Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Rapid Dose Therapeutics Corp C.DOSE

Alternate Symbol(s):  RDTCF

Rapid Dose Therapeutics Corp. is a Canadian biotechnology company. It provides disruptive drug delivery technologies designed to improve patient outcomes. Its flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient. It has one operating segment comprising production, distribution, research, and the provision of technical services for the delivery of oral thin film strips containing active ingredients. It offers over-the-counter and pharmaceutical drug delivery solutions. Its QuickStrip Energy delivers energizing caffeine. Its QuickStrip B12 delivers vitamin B12 to the system, assisting with metabolism and physical energy. Its QuickStrip Sleep delivers melatonin to the system, inducing natural and healthy sleep. QuickStrip Lidocaine is its dental product.


CSE:DOSE - Post by User

Post by Profiteeron Dec 04, 2022 11:56am
238 Views
Post# 35149494

The reasons I won't sell my DOSE shares (& plan to buy more)

The reasons I won't sell my DOSE shares (& plan to buy more)Regardless of the retail expansion...
Despite the filing delays... 

The research collaboration with McMaster University (a credible institution) has the potential to introduce a disruptive product:
  1. A vaccine strip that can solve the vaccine delivery & logistics issue, without the need of expensive cold storage distribution & no-needle injections.
  2. We're not just talking about Covid, but a viable drug delivery alternative for the pharmaceutical industry in general.
  3. It's a scalable product with indications for use worldwide.
  4. The research has already presented positive results. Further progress in research will likely result in media exposure/announcement (potentially resulting in an uptrend spike)
  5. One of 5 Canadian companies accepted into the Venture Mentoring Services (US/CAN) collaboration. If there wasn't aat least a viable business model, they would not have been selected.
<< Previous
Bullboard Posts
Next >>